Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study.
Faloppi L, Puzzoni M, Gardini AC, Silvestris N, Masi G, Marisi G, Vivaldi C, Gadaleta CD, Ziranu P, Bianconi M, Loretelli C, Demurtas L, Lai E, Giampieri R, Galizia E, Ulivi P, Battelli N, Falcone A, Cascinu S, Scartozzi M.
Faloppi L, et al. Among authors: giampieri r.
Target Oncol. 2020 Dec;15(6):801-802. doi: 10.1007/s11523-020-00773-3.
Target Oncol. 2020.
PMID: 33170485